102 related articles for article (PubMed ID: 1154557)
1. [Therapy of the carcinoma of the prostate and case control (III) (Author's transl)].
Alken CE; Dhom G; Straube W; Braun JS; Kopper B; Rehker H
Urologe A; 1975 May; 14(3):112-6. PubMed ID: 1154557
[TBL] [Abstract][Full Text] [Related]
2. [Morphology of the clinical stage O of the prostatic carcinoma (incidental carcinoma) (author's transl)].
Dhom G; Hautumm B
Urologe A; 1975 May; 14(3):105-11. PubMed ID: 50661
[TBL] [Abstract][Full Text] [Related]
3. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)].
Straube W; Braun JS
Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442
[No Abstract] [Full Text] [Related]
4. [Therapy of prostatic carcinoma and follow-up control (II)].
Alken CE; Dhom G; Straube W; Schmidt-Hermes HJ; Moormann JG; Moeller JF
Urologe A; 1973 Jul; 12(4):191-7. PubMed ID: 4726451
[No Abstract] [Full Text] [Related]
5. [Testosterone serum concentrations after subcapsular orchiectomy (author's transl)].
Senge T; Hülshoff T; Tunn U; Schenck B; Neumann F
Urologe A; 1978 Nov; 17(6):382-4. PubMed ID: 726161
[TBL] [Abstract][Full Text] [Related]
6. [Transrectal prostatosonography. Follow-up in prostate cancer therapy].
Dolz M; Drakopoulos A; Aurich B; Frentzel-Beyme B
Z Urol Nephrol; 1985 Sep; 78(9):465-74. PubMed ID: 3907200
[TBL] [Abstract][Full Text] [Related]
7. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
[TBL] [Abstract][Full Text] [Related]
8. [Testosterone in saliva: application to the follow-up of prostate cancer].
Navarro-Moreno MA; Rivera-Coll A
Rev Esp Fisiol; 1990 Mar; 46(1):63-8. PubMed ID: 2204093
[TBL] [Abstract][Full Text] [Related]
9. [Therapy and follow-up study of the prostatic neoplasm].
Alken CE; Dhom G; Hohbach M; Sachse D; Schröder FH; Straube W
Urologe A; 1972 Jul; 11(4):216-20. PubMed ID: 4341959
[No Abstract] [Full Text] [Related]
10. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
11. [Hormonal therapy of prostatic carcinoma].
Martz G
Internist (Berl); 1968 Sep; 9(9):375-80. PubMed ID: 4918657
[No Abstract] [Full Text] [Related]
12. [Morphological and clinical results after combined hormone and radiation therapy for carcinoma of the prostate (author's transl)].
Kastendieck H; Altenähr E; Burchardt P; Becker H; Franke HD; Klosterhalfen H
Dtsch Med Wochenschr; 1976 Apr; 101(15):571-6. PubMed ID: 1261373
[TBL] [Abstract][Full Text] [Related]
13. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
Daehlin L
Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
15. Combined androgen blockade in the management of advanced prostate cancer: a sensible or ostensible approach.
Ansari MS; Gupta NP; Hemal AK; Dogra PN; Seth A
Int J Urol; 2004 Dec; 11(12):1092-6. PubMed ID: 15663681
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.
Grande M; Carlström K; Rozell BL; Stege R; Pousette A
Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899
[TBL] [Abstract][Full Text] [Related]
17. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
18. [Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
Kuber W; Treu T; Kratzik C; Girsch E; Zeillinger R; Spona J
Wien Klin Wochenschr; 1990 Nov; 102(21):640-7. PubMed ID: 2148044
[TBL] [Abstract][Full Text] [Related]
19. [Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate].
Pavone-Macaluso M; Serretta V; Pavone C; Romano C; Daricello G
Arch Esp Urol; 1989; 42 Suppl 2():197-205. PubMed ID: 2534783
[TBL] [Abstract][Full Text] [Related]
20. Orchiectomy, estrogen therapy and radiotherapy in locally advanced (T3-4 M0) prostatic cancer.
Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
Scand J Urol Nephrol Suppl; 1988; 110():103-7. PubMed ID: 3187397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
